IL2 and Merkel cell skin cancer: 2.5. EpCAM-ReTARGTPRIFNαR149A Redirects TPR/IL2-Expanded PBMCs to Selectively Eliminate Primary Patient-Derived Merkel Cell Carcinoma Cells